Literature DB >> 19451067

Gamma Knife radiosurgery as a primary treatment option for solitary brain metastases from ovarian carcinoma.

A Navarro-Martín1, A Maitz, M Manders, E Ducharme, P Chen, I Grills.   

Abstract

We present three patients with brain metastasis cases from ovarian carcinoma (BMOC) treated at William Beaumont Hospital with a median follwow-up of 77 months and a mean survival after brain involvement of 23.66 months (range 5-44). Clinical and physical aspects are presented. Between December 2006 and August 2008, three cases of BMOC were treated using Gamma Knife (GK) radiosurgery. All patients had FIGO Stage III primary disease at initial diagnosis. Treatment sequences and features are described. GK achieves excellent local control of BMOC. Other parameters could be considered as biologically effective.

Entities:  

Mesh：

Year:  2009        PMID： 19451067     DOI： 10.1007/s12094-009-0362-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  16 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Memory function before and after whole brain radiotherapy in patients with and without brain metastases.

Authors:  Grit Welzel; Katharina Fleckenstein; Jörg Schaefer; Brigitte Hermann; Uta Kraus-Tiefenbacher; Sabine K Mai; Frederik Wenz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-28       Impact factor: 7.038

3.  Rapid-course radiation therapy of cerebral metastases: results and complications.

Authors:  D F Young; J B Posner; F Chu; L Nisce
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery.

Authors:  Edward Monaco; Douglas Kondziolka; Sanjay Mongia; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

5.  A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

Authors:  Jonathan P S Knisely; Brian Berkey; Arnab Chakravarti; Al W K Yung; Walter J Curran; H Ian Robins; Benjamin Movsas; David G Brachman; Randall H Henderson; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

Review 6.  Brain metastases from epithelial ovarian cancer: a review of the literature.

Authors:  Dimitrios Pectasides; Melina Pectasides; Theofanis Economopoulos
Journal:  Oncologist       Date:  2006-03

7.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

Authors:  E M Noordijk; C J Vecht; H Haaxma-Reiche; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-07-01       Impact factor: 7.038

8.  Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study.

Authors:  Yuta Shibamoto; Fumiya Baba; Kyota Oda; Shinya Hayashi; Masaki Kokubo; Shun-Ichi Ishihara; Yoshiyuki Itoh; Hiroyuki Ogino; Masahiko Koizumi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

9.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

10.  Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.

Authors:  Yoo-Kyung Lee; Noh-Hyun Park; Jae Weon Kim; Yong-Sang Song; Soon-Beom Kang; Hyo-Pyo Lee
Journal:  Gynecol Oncol       Date:  2008-01-11       Impact factor: 5.482
View more
  4 in total

1.  Gamma knife radiosurgery for the treatment of gynecologic malignancies metastasizing to the brain: clinical article.

Authors:  Matthew J Shepard; Francis Fezeu; Cheng-Chia Lee; Jason P Sheehan
Journal:  J Neurooncol       Date:  2014-08-17       Impact factor: 4.130

2.  Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients.

Authors:  Agata Celejewska; Andrzej Tukiendorf; Leszek Miszczyk; Krzysztof Składowski; Jerzy Wydmański; Krystyna Trela-Janus
Journal:  J Ovarian Res       Date:  2014-08-15       Impact factor: 4.234

3.  Association between Stereotactic Radiotherapy and Death from Brain Metastases of Epithelial Ovarian Cancer: a Gliwice Data Re-Analysis with Penalization

Authors:  Andrzej Tukiendorf; Mohammad Ali Mansournia; Jerzy Wydmański; Edyta Wolny-Rokicka
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

4.  Clinical Outcomes of Gamma Knife Radiosurgery for Metastatic Brain Tumors from Gynecologic Cancer : Prognostic Factors in Local Treatment Failure and Survival.

Authors:  Hong Kyung Shin; Jeong Hoon Kim; Do Heui Lee; Young Hyun Cho; Do Hoon Kwon; Sung Woo Roh
Journal:  J Korean Neurosurg Soc       Date:  2016-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.